1.Zonal differences in prostate diseases.
Chinese Medical Journal 2012;125(9):1523-1528
2.Chemical constituents from bark of Juglans mandshurica
Jin-Lan WANG ; Shu-Xia ZHANG ; Tie-Jun LI ; Wei-Qi ZHANG ; Jian-Jun WANG ; Shu-Jun ZHANG ;
Chinese Traditional and Herbal Drugs 1994;0(04):-
Objective To study the chemical constituents from the bark of Juglans mandshurica. Methods The compounds were isolated and purified by column chromatography on silica gel,HPLC,and recrystallization.Their structures were elucidated by the physicochemical and spectroscopic evidences. Results Fifteen compounds were identified as:4,8-dihydroxynaphthalenyl-O-?D-(6′-acetoxyl)gluco- pyranoside(Ⅰ),dihydrokaempferol(Ⅱ),juglone(Ⅲ),daucosterol(Ⅳ),kaempferol(Ⅴ),4,8-dihy- droxynaphthalenyl-1-O-?-D-[6′-O-(3″,5″-dimethoxy-4″-hydroxybenzoyl)] glucopyranoside(Ⅵ), kaempferol-3-O-?-L-rhamnoside(Ⅶ),3,3′-dimethoxylellagic acid(Ⅷ),naringenin(Ⅸ),quercetin (Ⅹ),reginolone(Ⅺ),quercetin-3-O-?-L-rhamnoside(Ⅻ),naringenin-7-O-?-D-glucoside(ⅩⅢ),4,8- dihydroxynaphthalenyl-1-O-?-glucoside(ⅩⅣ),4,5,8-trihydroxy-?-tetralone-5-O-?-D-[6′-O-(4″-hy- droxy-3″,5″-dimethoxy-benzoyl)] glucoside(ⅩⅤ).Conclusion CompoundⅠ(juglamanol)is a new compound.CompoundsⅡ,Ⅶ—Ⅸ,Ⅻ,andⅩⅢare isolated from plants of Carya Nutt.for the first time.
3.Mechanisms and function of angiopoietin.
Shu LIU ; Lü-ya WANG ; Heng-yi GUO ; Qi-xia WU
Chinese Journal of Pathology 2003;32(3):273-275
4.Primary keratinizing squamous cell carcinoma of the gallbladder: report of a case.
Wen-mang XU ; Xia LI ; Qi-chan HU ; Shu-ling SONG ; Li WANG ; Yuan-yuan WANG
Chinese Journal of Pathology 2012;41(12):853-854
Aged
;
Carcinoma, Squamous Cell
;
pathology
;
surgery
;
Cholecystectomy
;
Gallbladder Neoplasms
;
pathology
;
surgery
;
Humans
;
Male
5.Immigration and proliferation of Schwann cells in chemical acellular xenogeneousnerve grafts in rats
Bing-Yao CHEN ; Shu-Xun HOU ; Min ZHAO ; Yan-Xia QI ; Hong-Bin ZHONG ;
Chinese Journal of Microsurgery 2006;0(05):-
Objective To observed the immigration and proliferation of Schwann cells in acellular xe- no-nerve graft in rats.Methods The sciatic nerves on the right side of the rats were exposc.d and 0.8cm long segments of the nerves were removed from the mid-thigh level and replaced by 1.0cm long rabbit nerves made acellular through chemical extraction.After 4 months,the immigration and proliferation of Schwann cells in the graft were revealed by HE staining,S-100 immunohistochemieal staining and transmission electromicro- scope.Results In the rats repaired by acellular nerves,regenerated axons upgrow into the graft,and a- round regenerated axons there were abundant cells aligned,the cytoplasm of which were S-100 immunoreac- tive.Electromicroscope observing showed that regenerated axons were surrounded by myelin formed by the mi- grated cells reoccupied the acellular segments.Conclusion The host Schwann cells can immigrate into rab- bit nerve grafts made acellular through chemical extraction and form myelin enwrapping regenerated axons in rats.
6.The relationship between the levels of HBV DNA loads and both the clinical characteristics and 48-week prognosis in patients with decompensated cirrhosis due to hepatitis B
Qi-Huan XU ; Yu-Sheng JIE ; Shu-Zhen LIN ; Xia SHU ; Ni CHEN ; Qi-Feng XIE ; Gang LI
Chinese Journal of Experimental and Clinical Virology 2009;23(4):282-284
Objective To evaluate the relationship between the levels of HBV DNA loads and beth the clinical characteristics and 48-week prognosis in patients with decompensated cirrhosis due to hepatitis B. Methods One hundred and forty-three patients with deeompensated cirrhosis of hepatitis B virus infection were divided into lowlevel HBV DNA group [HBV DNA < 105 copies/ml = (46 cases) and high-level HBV-DNA group(HBV DNA 105 copies/ml)(97 cases)]. 21 cases in low-level group and 52 cases in high-level group treated with nucleoside analog. Results There was no significant difference between the two groups on the demography and the baseline in ALT, ALB, TBil, CHE before treatment, while in AST and HBeAg were statistically different. At 48-week, there was no significant difference between the two groups on the liver function. The mortality rate in low-level group was similar to that in high level group. In the low-level HBV DNA patients, hepatocellular carcinoma, spontaneous peritonitis and gnstrointestiual hemorrhage were higer than that in the high-level HBV DNA patients. Conclusion In patients with decompensated cirrhosis due to hepatitis B, those who were in low-level HBV DNA had not got better than that in high-level HBV DNA, which indicated that earlier treatment was also needed in low-level HBV DNA patients.
7.Cloning and tissue expression of 4-coumarate coenzyme A ligase gene in Angelica sinensis.
Sui-chao WEN ; Yin-quan WANG ; Jun LUO ; Qi XIA ; Qin FAN ; Shu-nan LI ; Zhen-heng WANG
China Journal of Chinese Materia Medica 2015;40(24):4824-4829
4-coumarate coenzyme A ligase is a key enzyme of phenylpropanoid metabolic pathway in higher plant and may regulate the biosynthesis of ferulic acid in Angelica sinensis. In this study, the homology-based cloning and rapid amplification of cDNA ends (RACE) technique were used to clone a full length cDNA encoding 4-coumarate coenzyme A ligase gene (4CL), and then qRT-PCR was taken for analyzing 4CL gene expression levels in the root, stem and root tissue at different growth stages of seedlings of A. sinensis. The results showed that a full-length 4CL cDNA (1,815 bp) was obtained (GenBank accession number: KT880508) which shares an open reading frame (ORF) of 1 632 bp, encodes 544 amino acid polypeptides. We found 4CL gene was expressed in all tissues including leaf, stem and root of seedlings of A. sinensis. The expressions in the leave and stem were increased significantly with the growth of seedlings of A. sinensis (P < 0.05), while it in the root showed little change. It indicates a time-space pattern of 4CL gene expression in seedlings of A. sinensis. These findings will be useful for establishing an experiment basis for studying the structure and function of 4CL gene and elucidating mechanism of ferulic acid biosynthesis and space-time regulation in A. sinensis.
Amino Acid Sequence
;
Angelica sinensis
;
genetics
;
Base Sequence
;
Cloning, Molecular
;
Coenzyme A Ligases
;
genetics
;
DNA, Complementary
;
chemistry
;
Molecular Sequence Data
8.Pregabalin attenuates docetaxel-induced neuropathy in rats.
Ping, PENG ; Qingsong, XI ; Shu, XIA ; Liang, ZHUANG ; Qi, GUI ; Yu, CHEN ; Yu, HUANG ; Man, ZOU ; Jie, RAO ; Shiying, YU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(4):586-90
Chemotherapy-induced neuropathy is a serious clinical problem for patients receiving cancer treatment. The aim of this study was to investigate the potential efficacy of pregabalin in chemotherapy-induced neuropathy in rats. A total of 35 male Sprague-Dawley rats were randomly divided into 5 groups: group 1, naive control; group 2, treated with pregabalin (30 mg/kg p.o., for 8 days); group 3, docetaxel was given by single intravenous infusion at 10 mg/kg; groups 4 and 5, pregabalin at 10 mg/kg and 30 mg/kg respectively was orally administered for 8 days after the docetaxel treatment. On day 8, behavioral test was performed, and substance P and CGRP release in dorsal root ganglion (DRG) and sciatic nerve were analyzed by electron microscope. Our results showed that docetaxel induced mechanical allodynia, mechanical hyperalgesia, heat hypoalgesia, cold allodynia, and sciatic nerve impairment and substance P and CGRP release in DRG. However, oral administration of pregabalin (10 mg/kg and 30 mg/kg) for 8 consecutive days significantly attenuated docetaxel-induced neuropathy by ameliorating heat hypoalgesia, cold allodynia, impairment of sciatic nerve and reducing the release of substance P and CGRP. The findings in the present study reveal that pregabalin may be a potential treatment agent against chemotherapy-induced neuropathy.
9.Efficacy of a Daltuzumab-containing Regimen in Patients with mSMART High-Risk Multiple Myeloma
Zhen-Lun QI ; Ya-Qin LUO ; Shu-Min DING ; Zhao-Xia LIU
Journal of Experimental Hematology 2024;32(3):774-779
Objective:To investigate the efficacy and safety of a treatment regimen based on daratumumab in patients with high-risk relapsed refractory multiple myeloma(MM)with mSMART 3.0 score.Methods:Clinical data were collected from 16 patients with mSMART3.0 score high-risk relapsed refractory MM treated at the Affiliated Hospital of Shandong University of Traditional Chinese Medicine from May 2020 to May 2023,all of whom received daltezumab-based regimen(regimen drugs including dexamethasone,isazomib,bortezomib,lenalidomide).The efficacy and safety of the treatment were retrospectively analyzed.Results:The median age of 16 patients was 63.5(47-70)years old,including 10 cases of IgG type,2 cases of IgA type,and 4 cases of light chain type.The curative efficacy was judged in all 16 patients,with an overall response rate of 93.75%(15/16),including 4 cases of strict complete remission(sCR),1 case of complete remission(CR),2 case of very good partial remission(VGPR),partial remission(PR)in 5 cases,and minor remission(MR)in 3 cases.The median follow-up time was 11(2-30)months,and the median progression-free survival and median overall survival were not achieved in 16 patients at the median follow-up period.The hematologic adverse effects of the treatment regimen using daratumumab-based were mainly neutropenia,and the non-hematologic adverse effects were mainly infusion-related adverse reactions and infections.Conclusion:Daratumumab-based regimen for the treatment of relapsed refractory MM patients with high risk of mSMART3.0 score has better efficacy and safety.
10.The analysis of IL-10 and its methylation in the patients with acute on chronic liver failure
Zhao-Xia QI ; Shu-Xia YU ; Hong-Sheng HAO ; Feng-Cai LI ; Zhao-Yang GUO ; Yu-Chen FAN ; Kai WANG
Chinese Journal of Experimental and Clinical Virology 2011;25(2):99-101
Objective To investigate the effect of IL-10 and the methylation of its promoter in acute on chronic liver failure (ACLF). Methods Patients were divided into three groups: 25 with ACLF, 25 with CHB, 10 healthy controls. Respectively detect the serum level of IL-10 via ELISA, and the methylation of 1L-10 promoter via MSP,to analyze the difference among the three groups. Results Both the ACLF group and the CHB group have significant increase in serum level of IL-10 compared with the control group ( P <0.05 ) ; the ACLF group's level is higher than the CHB group, however without statistical significance (P >0.05 ). The serum level of IL-10 in ACLF group has no significant relativity with ALT and HBV-DNA( r = -0. 022, r = 0. 033, respectively; P > 0. 05 ) ; has positive relativity with TBIL and MELD ( r = 0. 566, r =0.443, respectively; P < 0.05); and negative relativity with PTA (r = - 0.581, P < 0.05). The distribution of the methylation of IL-10 promoter in ACLF group is significantly different from the other two.Conclusion The serum level of IL-10 in hepatitis patients is significantly higher and increases with the degree of liver failure. The promoter methylation may be important in the gene inactivation.